Biosimilar therapy for breast cancer, zoledronic acid for bone metastases, the future of Obamacare under Donald Trump, and more
Editors’ Summary by Phil B. Fontanarosa, MD, MBA, Executive Editor of JAMA, the Journal of the American Medical Association, for the January 3, 2017 issue
Source: JAMA: This Week's Audio Commentary - Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
More News: American Medical Association (AMA) | Breast Cancer | Cancer | Cancer & Oncology | General Medicine | Reclast | Zometa